Effect of obesity on the effectiveness of hormonal contraceptives: an individual participant data meta-analysis

Contraception

Volumn 92, Issue 5, 2015, Pages 445-452

  Yamazaki, Michiyo ^a   Dwyer, Kate ^a   Sobhan, Mahboob ^a   Davis, Daniel ^a   Kim, Myong Jin ^a   Soule, Lisa ^a   Willett, Gerald ^a   Yu, Chongwoo ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Body mass index; Contraceptive effectiveness; Hazard ratio; Meta analysis; Obesity

Indexed keywords

DESOGESTREL PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS LEVONORGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE; ETHINYLESTRADIOL PLUS NORGESTIMATE; ORAL CONTRACEPTIVE AGENT; ETHINYLESTRADIOL PLUS NORGESTREL;

ARTICLE; BODY MASS; CLINICAL EFFECTIVENESS; HUMAN; META ANALYSIS; OBESITY; ORAL CONTRACEPTION; PHASE 3 CLINICAL TRIAL (TOPIC); PREGNANCY RATE; TRANSDERMAL PATCH; UNPLANNED PREGNANCY; COMPLICATION; CONTRACEPTION; DRUG EFFECTS; FEMALE; METABOLISM; NORTH AMERICA; PREGNANCY; PROCEDURES; PROPORTIONAL HAZARDS MODEL;

BODY MASS INDEX; CLINICAL TRIALS, PHASE III AS TOPIC; CONTRACEPTION; CONTRACEPTIVES, ORAL, COMBINED; ETHINYL ESTRADIOL-NORGESTREL COMBINATION; FEMALE; HUMANS; NORTH AMERICA; OBESITY; PREGNANCY; PREGNANCY RATE; PREGNANCY, UNPLANNED; PROPORTIONAL HAZARDS MODELS;

EID: 84945489588     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2015.07.016     Document Type: Article

References (45)

1. W.D. Mosher, and J. Jones Use of contraception in the United States: 1982-2008 Vital Health Stat 23 2010 1 44
2. J. Jones, W. Mosher, and K. Daniels Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995 National health statistics reports; no 60 2012 National Center for Health Statistics Hyattsville, MD
3. K. Daniels, W.D. Mosher, and J. Jones Contraceptive methods women have ever used: United States, 1982-2010 National health statistics reports; no 62 2013 National Center for Health Statistics Hyattsville, MD
4. L.B. Finer, and M.R. Zolna Unintended pregnancy in the United States: incidence and disparities, 2006 Contraception 84 2011 478 485
5. A. Sonfield, K. Kost, R.B. Gold, and L.B. Finer The public costs of births resulting from unintended pregnancies: national and state-level estimates Perspect Sex Reprod Health 43 2011 94 102
6. T.H. Fakhouri, C.L. Ogden, M.D. Carroll, BK Kit, and KM Flegal Prevalence of obesity among older adults in the United States, 2007-2010 NCHS data brief, no 106 2012 National Center for Health Statistics Hyattsville, MD
7. M.J. Hanley, D.R. Abernethy, and D.J. Greenblatt Effect of obesity on the pharmacokinetics of drugs in humans Clin Pharmacokinet 49 2010 71 87
8. A. Edelman, N. Carlson, G. Cherala, M Munar, R Stouffer, J Cameron, and et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity Contraception 80 2009 119 127
9. J.W. Goldzieher, and F.Z. Stanczyk Oral contraceptives and individual variability of circulating levels of ethinyl estradiol and progestins Contraception 78 1 2008 4 9
10. C.L. Westhoff, A.H. Torgal, E.R. Mayeda, M.C. Pike, and F.Z. Stanczyk Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women Contraception 81 2010 474 480
11. http://www.accessdata.fda.gov/drugsatfda-docs/label/2014/021529s008lblrev.pdf [Accessed on June 4, 2015]
12. http://www.accessdata.fda.gov/drugsatfda-docs/label/2014/021180Orig1s046lbl.pdf [Accessed on June 4, 2015]
13. C. Moreau, and J. Trussel Results from pooled Phase III studies of ulipristal acetate for emergency contraception Contraception 86 2012 673 680
14. A.F. Glasier, S.T. Cameron, D.L. Blithe, B Scherrer, H Mathe, D Levy, and et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel Contraception 84 2011 363 367
15. http://www.ema.europa.eu/ema/index.jsp?curl=pages/news-and-events/news/2014/07/news-detail-002145.jsp&mid=WC0b01ac058004d5c1 [Accessed on June 4, 2015]
16. L.M. Lopez, D.A. Grimes, M. Chen-Mok, C Westhoff, A Edelman, and FM Helmerhorst Hormonal contraceptives for contraception in overweight or obese women Cochrane Database Syst Rev 7 2010 [Art. No.: CD008452]
17. J.C. Dinger, L.A. Heinemann, and D. Kühl-Habich The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives (EURAS-OC) based on 142,475 women-years of observation Contraception 75 2007 344 354
18. J.C. Dinger, M. Cronin, S. Möhner, I Schellschmidt, TD Minh, and C Westoff Oral contraceptive effectiveness according to body mass index, weight, age, and other factors Am J Obstet Gynecol 2009 201263.e1 201263.e9
19. G.S. Merki-Feld, S. Skouby, D. Serfaty, M Lech, J Bitzer, PG Crosignani, and et al. European Society of Contraception Statement on Contraception in Obese Women Eur J Contracept Reprod Health Care 20 2015 19 28
20. J.P.T. Higgins, D.G. Altman, and J.A.C. Sterne Chapter 8: Assessing risk of bias in included studies J.P.T. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 2011 The Cochrane Collaboration [updated March 2011]
21. http://ipdmamg.cochrane.org/about-ipd-meta-analyses [Accessed on August 15, 2014]
22. L.A. Stewart, and J.F. Tierney To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data Eval Health Prof 25 2002 76 97
23. S.G. Thompson, and J.P. Higgins Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet 365 2005 341 346
24. A.J. Sutton, D. Kendrick, and C.A. Coupland Meta-analysis of individual- and aggregate-level data Stat Med 27 2008 651 669
25. http://apps.who.int/bmi/index.jsp?introPage=intro-3.html [Accessed on June 4, 2015]
26. R. Pearl Factors in human fertility and their statistical evaluation Lancet 2 1993 607 611
27. L.V. Hedges, and I. Olkin Statistical methods for meta-analysis 2002 Academic Press. Huffcutt, A.I Orland, FL
28. N. Mantel, and M.W. Haenszel Statistical aspects of thee analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
29. A. Liberati, D.G. Altman, J. Tetzlaff, C Mulrow, PC Gøtzsche, JP Ioannidis, and et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration BMJ 339 2009 b2700
30. R.D. Riley, P.C. Lambert, and G. Abo-Zaid Meta-analysis of individual participant data: rationale, conduct, and reporting BMJ 340 2010 c221
31. M.C. Simmonds, J.P. Higgins, L.A. Stewart, JF Tierney, MJ Clarke, and SG Thompson Meta-analysis of individual patient data from randomized trials: a review of methods used in practice Clin Trials 2 2005 209 217
32. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
33. M. Egger, S.G. Davey, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
34. Sex and America's Teenagers 8th ed. 1994 Alan Guttmacher Institute New York 36
35. M.J. Rosenberg, M.S. Waugh, and T.E. Meehan Use and misuse of oral contraceptives: risk indicators for poor pill-taking and discontinuation Contraception 51 1996 283 288
36. D.F. Archer, A. Bigrigg, G.H. Smallwood, GA Shangold, GW Creasy, and AC Fisher Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women Fertil Steril 77 Suppl. 2 2002 S27 S31
37. L.S. Peterson, D. Oakley, L.S. Potter, and J.E. Darroch Women's efforts to prevent pregnancy: consistency of oral contraceptive use Fam Plan Perspect 30 1 1998 19 23
38. A.M. Kaunitz, D.F. Archer, and M. Foegh Increased compliance with a low-dose combination contraceptive patch (AG200-15) compared with a low-dose combination oral contraceptive in a Phase 3 clinical trial [abstract] Contraception 86 2012 173 186
39. N. Bajos, K. Willings, C. Laborde, and C. Moreau CSF Group. Sexuality and obesity, a gender perspective: results from French national random probability survey of sexual behaviors BMJ 340 2010 c2573
40. H. Fu, J.E. Darroch, T. Haas, and N. Ranjit Contraceptive failure rates: new estimates from the 1995 National Survey of Family Growth Fam Plan Perspect 31 1999 56 63
41. K. Kost, S. Singh, B. Vaughan, J. Trussell, and A. Bankole Estimates of contraceptive failure from the 2002 National Survey of Family Growth Contraception 77 2008 10 21
42. C.L. Westhoff, K.A. Petrie, and S. Cremers Using changes in binding globulins to assess oral contraceptive compliance Contraception 87 2013 176 181
43. C.L. Westhoff, A.T. Torgal, E.R. Mayeda, N. Shimoni, F.Z. Stanczyk, and M.C. Pike Predictors of noncompliance in an oral contraceptive clinical trial Contraception 85 2012 465 469
44. C.L. Westoff, I. Reinecke, K. Bangerter, and M. Merz Impact of body mass index on suppression of follicular development and ovulation using a transdermal patch containing 0.55-mg ethinyl estradiol/2.1-mg gestodene: a multicenter, open-label, uncontrolled study over three treatment cycles Contraception 90 2014 272 279
45. C.L. Westhoff, A.H. Torgal, E.R. Mayeda, F.Z. Stanczyk, J.P. Lerner, E.K.T. Benn, and et al. Ovarian Suppression in Normal-Weight and Obese Women During Oral Contraceptive. A Randomized Controlled Trial 116 2010 275 283